Larimar Therapeutics (LRMR) Stock Chart & Stock Price History $3.88 +0.13 (+3.47%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$3.87 -0.01 (-0.26%) As of 07/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Larimar Therapeutics Stock Price Performance The Larimar Therapeutics (LRMR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.24%, with a year-to-date return of 0.26%. In the past month, the stock has increased 25.97%, reflecting recent market activity. As of the latest close, Larimar Therapeutics traded at $3.88 with a market cap of $248.44 million and volume of 722,552 shares. Receive LRMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+19.02%1 Month Performance+25.97%3 Month Performance+66.52%Year-To-Date Performance+0.26%1 Year Performance-59.24% LRMR Stock Chart for Saturday, July, 26, 2025 LRMR Chart by TradingView Larimar Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$3.75$3.88+3.47%$3.91$3.66722,552 shs$248.44 million07/24/2025$3.76$3.75-0.27%$4.01$3.651.26 million shs$240.11 million07/23/2025$3.38$3.76+11.24%$3.83$3.371.84 million shs$240.75 million07/22/2025$3.26$3.38+3.68%$3.53$3.251.12 million shs$216.42 million07/21/2025$3.21$3.26+1.56%$3.35$3.17471,079 shs$208.74 million07/18/2025$3.32$3.21-3.31%$3.37$3.14480,386 shs$205.54 million07/17/2025$3.20$3.32+3.75%$3.40$3.13750,782 shs$212.57 million07/16/2025$3.16$3.20+1.27%$3.31$3.12835,083 shs$204.90 million07/15/2025$3.45$3.16-8.41%$3.55$3.11853,445 shs$202.34 million07/14/2025$3.38$3.45+2.07%$3.68$3.36897,211 shs$220.90 million Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$3.48$3.38-2.87%$3.48$3.34686,334 shs$216.42 million07/10/2025$3.46$3.48+0.58%$3.50$3.30708,572 shs$222.82 million07/09/2025$3.32$3.46+4.22%$3.57$3.37719,781 shs$221.54 million07/08/2025$3.20$3.32+3.75%$3.49$3.201.04 million shs$212.58 million07/07/2025$3.14$3.20+1.91%$3.22$3.01811,364 shs$204.89 million07/04/2025$3.14$3.14$3.22$3.06516,014 shs$201.05 million07/03/2025$3.11$3.14+0.96%$3.22$3.06516,014 shs$201.05 million07/02/2025$2.88$3.11+7.99%$3.19$2.82877,299 shs$199.13 million07/01/2025$2.89$2.88-0.35%$2.98$2.81665,803 shs$184.41 million06/30/2025$3.03$2.89-4.62%$3.09$2.85653,129 shs$185.05 million06/27/2025$3.08$3.03-1.62%$3.14$2.931.91 million shs$194.01 million06/26/2025$3.25$3.08-5.23%$3.26$2.871.56 million shs$197.21 million06/25/2025$2.99$3.25+8.70%$3.33$2.882.03 million shs$208.10 million Related Companies Iovance Biotherapeutics Stock Price Chart uniQure Stock Price Chart Xeris Biopharma Stock Price Chart Nuvation Bio Stock Price Chart Trevi Therapeutics Stock Price Chart KalVista Pharmaceuticals Stock Price Chart Cronos Group Stock Price Chart Sionna Therapeutics Stock Price Chart Oculis Stock Price Chart Vir Biotechnology Stock Price Chart Receive LRMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LRMR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
